Arvinas, Inc. announced the appointment of Randy Teel, Ph.D., to the newly created role of Chief Business Officer. Dr. Teel currently serves as Arvinas? interim Chief Financial Officer and Treasurer, and in his new role, he will remain a member of the Executive Committee reporting to Chairperson, President and Chief Executive Officer, John Houston, Ph.D. Dr. Teel will remain in these interim roles at Arvinas while the board of directors continues its search for a permanent Chief Financial Officer and Treasurer.

Dr. Teel has nearly 20 years of experience in the biopharmaceutical industry. At Arvinas, in addition to finance, he also leads corporate strategy, business development, investor relations, and communications.